Jack Anders - 23 Oct 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Chief Financial Officer
Signature
/s/ Jack Anders
Issuer symbol
RVMD
Transactions as of
23 Oct 2023
Net transactions value
+$72,967
Form type
4
Filing time
23 Oct 2023, 18:01:14 UTC
Previous filing
20 Sep 2023
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $51,957 +19,387 +36% $2.68* 73,054 23 Oct 2023 Direct F1
transaction RVMD Common Stock Options Exercise $21,010 +5,137 +7% $4.09* 78,191 23 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -19,387 -46% $0.000000 22,814 23 Oct 2023 Common Stock 19,387 $2.68 Direct
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -5,137 -100% $0.000000* 0 23 Oct 2023 Common Stock 5,137 $4.09 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 40,800 restricted stock units.